Britain’s private healthcare sector is about to enter a new chapter after Spire Healthcare, the country’s largest private hospital operator, agreed to a £1.03bn takeover by an investment group led by Toscafund Asset Management.
The deal values Spire at 250p per share, bringing the company under the influence of Martin Hughes, the veteran City investor whose aggressive activist style has earned him the nickname “the Rottweiler.” Toscafund was already Spire’s second-largest shareholder before leading the takeover bid.
Spire operates 38 hospitals and more than 60 clinics across England, Wales and Scotland. In 2025, its network treated around 1.36 million patients, making the transaction significant not only for investors but also for Britain’s wider healthcare landscape.
Hughes has presented the takeover as an opportunity to give Spire greater freedom to invest for the long term. He said private ownership could allow the company to move faster, invest in its hospitals and workforce, introduce new technology and raise standards of patient care.
But the deal arrives at a politically sensitive moment.
The expansion of private companies within Britain’s health system has increasingly raised questions about the boundary between public healthcare and commercial interests. Research published earlier this year found that private companies providing services to the NHS, including healthcare and consultancy firms, generated £1.6bn in profits over two years.
Spire itself has experienced a turbulent period. The company launched a strategic review last September after entering discussions with potential buyers. Earlier negotiations with private equity firms Bridgepoint and Triton collapsed in March, leaving Toscafund to emerge as the eventual bidder.
For Spire, rising operating costs have added to the pressure. The company has faced higher expenses from increased National Insurance contributions and the rising minimum wage. Chair designate Debbie White said the business had experienced considerable volatility and argued that Toscafund’s existing knowledge of the company made it a natural buyer.
Investors appeared to welcome the agreement, with Spire shares rising 3.2% in early trading to around 246p.
Yet beyond the share price lies a bigger question.
When one of Britain’s largest private healthcare providers changes hands for more than £1bn, the transaction is not simply about who owns the hospitals. It also raises questions about how healthcare should be funded, managed and delivered in a country where the NHS and private medicine increasingly operate alongside each other.
